Hasil Pencarian - Hongzhi Geng

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    P1186: RETROSPECTIVE STUDY: ZANUBRUTINIB COMBINED WITH R-CHOP OR R-CHOP REGIMEN IN THE TREATMENT OF UNTREATED NON-GERMINAL CENTER B-CELL SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA WITH EXTRANODAL INVOLVEMENT.

    P1186: RETROSPECTIVE STUDY: ZANUBRUTINIB COMBINED WITH R-CHOP OR R-CHOP REGIMEN IN THE TREATMENT OF UNTREATED NON-GERMINAL CENTER B-CELL SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA WITH... oleh LI Caixia, Hongzhi Geng, Xiangping Zong, Ying Zhang, Sixun Jia, LI Jiaqi, Jin Zhou, Depei Wu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma

    Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma oleh Jin Zhou, Jin Zhou, Jin Zhou, Ying Zhang, Ying Zhang, Ying Zhang, Meng Shan, Meng Shan, Meng Shan, Xiangping Zong, Xiangping Zong, Xiangping Zong, Hongzhi Geng, Hongzhi Geng, Hongzhi Geng, Jiaqi Li, Jiaqi Li, Jiaqi Li, Guanghua Chen, Guanghua Chen, Guanghua Chen, Lei Yu, Yang Xu, Yang Xu, Yang Xu, Caixia Li, Caixia Li, Caixia Li, Depei Wu, Depei Wu, Depei Wu

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    PB2289: PRELIMINARY DATA FROM A FIRST-IN HUMAN PHASE II STUDY OF SEQUENTIAL USE OF SELINEXOR AND CD19 CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELL THERAPY (CART19) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

    PB2289: PRELIMINARY DATA FROM A FIRST-IN HUMAN PHASE II STUDY OF SEQUENTIAL USE OF SELINEXOR AND CD19 CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELL THERAPY (CART19) IN PATIENTS WITH RE... oleh Ying Zhang, Xiangping Zong, Jiaqi LI, Sixun Jia, Hongzhi Geng, Liangyu Zeng, Qin Yang, Wenzhi Cai, Shuangzhu Liu, Yutong Lu, Lei Yu, Caixia LI, Depei Wu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

    A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma oleh Ying Zhang, Ying Zhang, Ying Zhang, Jiaqi Li, Jiaqi Li, Jiaqi Li, Xiaoyan Lou, Xiaochen Chen, Xiaochen Chen, Xiaochen Chen, Zhou Yu, Liqing Kang, Jia Chen, Jia Chen, Jia Chen, Jin Zhou, Jin Zhou, Jin Zhou, Xiangping Zong, Xiangping Zong, Xiangping Zong, Zhen Yang, Zhen Yang, Zhen Yang, Minghao Li, Nan Xu, Sixun Jia, Sixun Jia, Sixun Jia, Hongzhi Geng, Hongzhi Geng, Hongzhi Geng, Guanghua Chen, Guanghua Chen, Guanghua Chen, Haiping Dai, Haiping Dai, Haiping Dai, Xiaowen Tang, Xiaowen Tang, Xiaowen Tang, Lei Yu, Lei Yu, Depei Wu, Depei Wu, Depei Wu, Caixia Li, Caixia Li, Caixia Li

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement

    Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement oleh Hongzhi Geng, Hongzhi Geng, Sixun Jia, Ying Zhang, Ying Zhang, Jiaqi Li, Jiaqi Li, Jiaqi Li, Jiaqi Li, Qin Yang, Qin Yang, Liangyu Zeng, Liangyu Zeng, Xiangping Zong, Xiangping Zong, Xiangping Zong, Xiangping Zong, Yutong Lu, Yutong Lu, Yutong Lu, Yutong Lu, Shuangzhu Lu, Shuangzhu Lu, Shuangzhu Lu, Shuangzhu Lu, Jin Zhou, Jin Zhou, Jin Zhou, Jin Zhou, Caixia Li, Caixia Li, Caixia Li, Caixia Li, Depei Wu, Depei Wu, Depei Wu, Depei Wu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma

    Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma oleh Wei Sang, Wei Sang, Wei Sang, Xiangmin Wang, Xiangmin Wang, Xiangmin Wang, Hongzhi Geng, Tianci Li, Tianci Li, Tianci Li, Dashan Li, Dashan Li, Dashan Li, Bingpei Zhang, Bingpei Zhang, Bingpei Zhang, Yi Zhou, Yi Zhou, Yi Zhou, Xuguang Song, Xuguang Song, Xuguang Song, Cai Sun, Cai Sun, Cai Sun, Dongmei Yan, Dongmei Yan, Dongmei Yan, Depeng Li, Depeng Li, Depeng Li, Zhenyu Li, Zhenyu Li, Zhenyu Li, Caixia Li, Kailin Xu, Kailin Xu, Kailin Xu

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: